BioCentury
ARTICLE | Emerging Company Profile

Anticancer Bioscience: applying synthetic lethality to MYC-driven cancers

Emerging Company Profile: Chengdu-based ACB joins a growing wave of next-gen synthetic lethality companies 

June 14, 2021 2:44 PM UTC


Access this Article

BCIQ Company Profiles

Anticancer Bioscience Ltd.